治疗肝硬化的新兴合成药物：2024 年最新进展

IF 2.7 3区医学 Q2 PHARMACOLOGY & PHARMACY

Expert Opinion on Emerging Drugs Pub Date : 2024-04-11 DOI:10.1080/14728214.2024.2341878

Jonathan A Fallowfield, Maria Jimenez Ramos

引用次数: 0

摘要

发表于《新兴药物专家意见》（刚刚接受，2024 年）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Emerging synthetic drugs for the treatment of hepatic cirrhosis: a 2024 update

Published in Expert Opinion on Emerging Drugs (Just accepted, 2024)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Expert Opinion on Emerging Drugs 医学-药学

CiteScore

5.90

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.